Lead drug PGN-EDO51 targets a mutation in the dystrophin gene that can be treated by skipping exon 51, making it a potential rival to Sarepta Pharma's Exondys 51 (eteplirsen), which made $454 ...

Investment in mining and exploration companies.

A New York appeals court grilled attorneys for both Donald Trump and the New York attorney general’s office Thursday over the $454 million civil fraud judgment against the former president ...

An online community for late model GM V8 engine performance enthusiasts. When you click on links to various merchants on this site and make a purchase, this can result in this site earning a ...